1. Home
  2. |Insights
  3. |29th Annual Drug & Medical Device Litigation Conference

29th Annual Drug & Medical Device Litigation Conference

Event | 12.03.24, 8:30 AM EST - 9:30 AM EST | CLE Offered

Address

New York Marriott Marquis
1535 Broadway, New York, NY 10036

Andrew Kaplan will speak on the panel "Drug and Medical Device Litigation Year in Review" which will explore these critical changes, dissecting their real-world impacts and forecasting their influence on future litigation trends and strategies. Topics of discussion will include:
  •  Surveying the year’s most significant and influential court decisions involving drug and medical device claims
  • Analyzing pending decisions that may have the most foreseeable future impact
  • Updating practice and litigation strategies in response to the latest case law development
  • Coordinating within the defense bar to “level the playing field”

For more information, please visit these areas: Mass Tort, Product, and Consumer Litigation, Class Action Defense, Litigation and Trial, Torts Class Actions, Medical Devices, Product Risk Management, National Coordinating Counsel and Complex Litigation, Life Sciences

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.